About Ceepax Pharma Private Limited
Data last updated:
Ceepax Pharma Private Limited is a private limited company based in Jabalpur, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74994MP2019PTC048371.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhaskar Ghuratia and Jitendra Kumar Namdeo.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 12 Ukhari Road Vivekanand Ward Ektanagar Jabalpur, Madhya Pradesh, India – 482002.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.12 Lakh, a decline of 67% compared to the previous year. For the same year it recorded a net loss of ₹4.75 Lakh (net margin -46.9%) and EBITDA of -₹2.71 Lakh (EBITDA margin -26.7%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
For more details, the company can be reached via its website ceepax.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressH No. 12 Ukhari Road Vivekanand Ward Ektanagar Jabalpur, Madhya Pradesh, India – 482002
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ceepax Pharma Private Limited
The main business activity of Ceepax Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ceepax Pharma Private Limited FY 2025 filings available
Ceepax Pharma Private Limited reported revenue of ₹10.12 Lakh (down 67% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Ceepax Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 67% fall in the latest year. EBITDA fell 210% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ceepax Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.71 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.75 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Ceepax Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -26.7% | •••• | •••• | •••• |
| Net Profit Margin | -46.9% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ceepax Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ceepax Pharma Private Limited
Ceepax Pharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vitacare Pharma Private Limited | ₹10.31 Lakh (FY 2024) | •••• | •••• | 288.0% | •••• | Delhi, India |
| Curaremedy Medicos (OPC) Private Limited | ₹10.3 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Gurugram, Haryana, India |
| Ani Pharma Private Limited | ₹10.3 Lakh (FY 2021) | •••• | •••• | 32.0% | •••• | Jalgaon, Maharashtra, India |
| Galaxy Offshore and Oilfield Private Limited | ₹10.22 Lakh (FY 2025) | •••• | •••• | 39.0% | •••• | Mumbai, Maharashtra, India |
| Byte Wellness Private Limited | ₹10.16 Lakh (FY 2025) | •••• | •••• | 19413.0% | •••• | Ponneri, Tamil Nadu, India |
| Ceepax Pharma Private Limited this company | ₹10.12 Lakh (FY 2023) | •••• | •••• | -67.0% | •••• | Jabalpur, Madhya Pradesh, India |
| Eikonax Innovative Solutions Private Limited | ₹9.96 Lakh (FY 2025) | •••• | •••• | -62.0% | •••• | Kunjibettu, Karnataka, India |
| Medlife Pharma Healthcare Private Limited | ₹9.9 Lakh (FY 2024) | •••• | •••• | •••• | Jalgaon, Maharashtra, India | |
| HKS Devamrit Private Limited | ₹9.87 Lakh (FY 2024) | •••• | •••• | 68.0% | •••• | New Delhi, Delhi, India |
| Fidelity Pharma Private Limited | ₹9.87 Lakh (FY 2023) | •••• | •••• | 42.0% | •••• | Bangalore, Karnataka, India |
| Preetikaya Lifestyle Solutions Private Limited | ₹9.85 Lakh (FY 2025) | •••• | •••• | -60.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ceepax Pharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ceepax Pharma Private Limited
Ceepax Pharma Private Limited is audited by CHETAN DHAWAN & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| CHETAN DHAWAN & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ceepax Pharma Private Limited
Ceepax Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhaskar Ghuratia | Director | 30 Mar 2021 | 5 Years 6 Months | Current |
| Jitendra Kumar Namdeo | Director | 04 Feb 2024 | 2 Years 8 Months | Current |
Ownership and Shareholding of Ceepax Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ceepax Pharma Private Limited
Ceepax Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ceepax Pharma Private Limited
Employment history and EPFO contributions of people linked to Ceepax Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ceepax Pharma Private Limited
Ceepax Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Manali Namdeo ceased to be Director on 06 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Ceepax Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ceepax Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ceepax Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ceepax Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ceepax Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceepax Pharma Private Limited
Ceepax Pharma is an active private limited company based in Jabalpur, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U74994MP2019PTC048371.
Ceepax Pharma reported revenue of ₹10.12 Lakh for FY 2023 (down 67% YoY).
Ceepax Pharma has 2 current directors:
- Bhaskar Ghuratia - Director
- Jitendra Kumar Namdeo - Director
Ceepax Pharma reported a net loss of ₹4.75 Lakh (net margin -46.9%) and EBITDA of -₹2.71 Lakh (EBITDA margin -26.7%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ceepax Pharma is -7% over three years. In the latest year (FY 2023) revenue fell 67%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Ceepax Pharma is U74994MP2019PTC048371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceepax Pharma was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Ceepax Pharma by revenue are Vitacare Pharma Private Limited, Curaremedy Medicos (OPC) Private Limited, Ani Pharma Private Limited, Galaxy Offshore and Oilfield Private Limited, Byte Wellness Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Manali Namdeo ceased to be Director on 06 Feb 2024. Jitendra Kumar Namdeo was appointed as Director on 04 Feb 2024. Jitendra Kumar Namdeo ceased to be Director on 10 Apr 2021. Ceepax Pharma has 4 board changes on record in total.
Ceepax Pharma can be reached through the website ceepax.com. Its registered office is in Jabalpur, Madhya Pradesh, India.
The registered office of Ceepax Pharma is at H No. 12 Ukhari Road Vivekanand Ward Ektanagar Jabalpur, Madhya Pradesh, India – 482002.